Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden

International Journal of Gynecological Cancer

Volumn 22, Issue 8, 2012, Pages 1413-1419

  Larsson, Gabriella Lillsunde ^a,b   Helenius, Gisela ^a,b   Andersson, Soren ^a,b   Elgh, Fredrik ^c   Sorbe, Bengt ^a   Karlsson, Mats G ^a,b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HPV 16 variants; Human papillomavirus; Vulvar carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL LINEAGE; CONTROLLED STUDY; E6 GENE; FEMALE; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; MAJOR CLINICAL STUDY; MIXED TUMOR; NONHUMAN; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PYROSEQUENCING; RECURRENCE FREE SURVIVAL; SPECIES DISTRIBUTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME; TUMOR VOLUME; VERRUCOUS CARCINOMA; VIRUS DETECTION; VIRUS GENE; VULVA CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SWEDEN; VULVAR NEOPLASMS;

EID: 84867268780     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31826a0471     Document Type: Article

References (25)

1. The National Board of Health and Welfare. Cancer Incidence in Sweden 2009. Stockholm, Sweden: Socialstyrelsen; 2010.
2. Mccluggage WG. Recent developments in vulvovaginal pathology. Histopathology. 2009;54:156-173.
3. Ueda Y, Enomoto T, Kimura T, et al. Two distinct pathways to development of squamous cell carcinoma of the vulva. J Skin Cancer. 2011;2011:951250.
4. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110:S4YS7.
5. De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626-1636.
6. De Koning MN, Quint WG, Pirog EC. Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma. Mod Pathol. 2008;21:334-344.
7. Sutton BC, Allen RA, Moore WE, et al. Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva. Mod Pathol. 2008;21:345-354.
8. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol. 1991;10:107-125.
9. Lindell G, Nasman A, Jonsson C, et al. Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. Gynecol Oncol. 2010;117:312-316.
10. Monk BJ, Burger RA, Lin F, et al. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol. 1995;85:709-715.
11. Pinto AP, Schlecht NF, Pintos J, et al. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol. 2004;92:856-865.
12. Alonso I, Fuste V, Del Pino M, et al. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? Gynecol Oncol. 2011;122:509-514.
13. Huertas-Salgado A, Martin-Gamez DC, Moreno P, et al. E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature. Virology. 2010;410:201-215.
14. Ho L, Chan SY, Burk RD, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol. 1993;67:6413-6423.
15. Yamada T, Wheeler CM, Halpern AL, et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69:7743-7753.
16. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71:2463-2472.
17. Swan DC, Rajeevan M, Tortolero-Luna G, et al. Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol. 2005;96:695-700.
18. Grodzki M, Besson G, Clavel C, et al. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev. 2006;15:820-822.
19. Kammer C, Tommasino M, Syrjanen S, et al. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer. 2002;86:269-273.
20. Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998;58:829-833.
21. Ellis JR, Keating PJ, Baird J, et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995;1: 464-470.
22. Etherington IJ, Ellis JR, Luesley DM, et al. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol. 1999;72:56-59.
23. Lindh M, Gorander S, Andersson E, et al. Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol. 2007;40:321-324.
24. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol. 2003;41:3221-3228.
25. Swan DC, Limor JR, Duncan KL, et al. Human papillomavirus type 16 variant assignment by pyrosequencing. J Virol Methods. 2006;136:166-170.